We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
Cap. Flow
+$2.5B
Cap. Flow %
2.6%
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$410M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$308M
3
LLY icon
Eli Lilly
LLY
+$292M
4
COST icon
Costco
COST
+$291M
5
F icon
Ford
F
+$257M

Sector Composition

Rank Sector Weight
1 Technology 10.55%
2 Consumer Discretionary 7.1%
3 Financials 4.87%
4 Healthcare 4.79%
5 Industrials 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUE icon
2851
Monte Rosa Therapeutics
GLUE
$1.87B
$803K ﹤0.01%
+178,136
New +$795K
CCK icon
2852
PUT
Crown Holdings
CCK
$12.9B
$803K ﹤0.01%
+7,800
New +$743K
TAP icon
2853
CALL
Molson Coors Class B
TAP
$8.07B
$803K ﹤0.01%
16,700
+2,600
+18% +$143K
CFFN icon
2854
Capitol Federal Financial
CFFN
$1.08B
$803K ﹤0.01%
131,625
+932
+0.7% +$5.28K
BWB icon
2855
Bridgewater Bancshares
BWB
$586M
$802K ﹤0.01%
50,396
+32,398
+180% +$475K
WM icon
2856
CALL
Waste Management
WM
$96.8B
$801K ﹤0.01%
3,500
-15,300
-81% -$3.55M
NAVI icon
2857
Navient
NAVI
$821M
$800K ﹤0.01%
56,744
+5,087
+10% +$65.4K
CORT icon
2858
CALL
Corcept Therapeutics
CORT
$10.3B
$800K ﹤0.01%
10,900
+7,800
+252% +$566K
LOVE icon
2859
LoveSac
LOVE
$250M
$799K ﹤0.01%
43,923
-27,556
-39% -$523K
MKL icon
2860
CALL
Markel Group
MKL
$25.3B
$799K ﹤0.01%
+400
New +$750K
ALNY icon
2861
Alnylam Pharmaceuticals
ALNY
$38.6B
$798K ﹤0.01%
2,446
-3,822
-61% -$1.06M
BKLN icon
2862
PUT
Invesco Senior Loan ETF
BKLN
$6.97B
$795K ﹤0.01%
38,000
-26,000
-41% -$540K
DTE icon
2863
DTE Energy
DTE
$30.4B
$794K ﹤0.01%
5,995
+16
+0.3% +$2.15K
YPF icon
2864
CALL
YPF
YPF
$19.8B
$793K ﹤0.01%
25,200
+8,700
+53% +$290K
OMCL icon
2865
Omnicell
OMCL
$1.96B
$792K ﹤0.01%
26,924
-134,174
-83% -$4.01M
ABEV icon
2866
Ambev
ABEV
$48.4B
$791K ﹤0.01%
328,262
+262,941
+403% +$640K
RARE icon
2867
Ultragenyx Pharmaceutical
RARE
$2.53B
$788K ﹤0.01%
21,683
-198,201
-90% -$7.15M
MYGN icon
2868
Myriad Genetics
MYGN
$505M
$788K ﹤0.01%
148,335
+68,208
+85% +$403K
WSBC icon
2869
WesBanco
WSBC
$4.02B
$787K ﹤0.01%
24,871
-37,927
-60% -$1.15M
WBD icon
2870
Warner Bros
WBD
$64.2B
$787K ﹤0.01%
68,644
-7,902
-10% -$73.7K
IDYA icon
2871
IDEAYA Biosciences
IDYA
$3.48B
$786K ﹤0.01%
37,389
-51,937
-58% -$996K
ESI icon
2872
Element Solutions
ESI
$8.8B
$786K ﹤0.01%
34,689
+3,944
+13% +$82.7K
IEF icon
2873
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$783K ﹤0.01%
8,178
ALGM icon
2874
CALL
Allegro MicroSystems
ALGM
$8.29B
$783K ﹤0.01%
+22,900
New +$570K
SAM icon
2875
PUT
Boston Beer
SAM
$1.95B
$782K ﹤0.01%
+4,100
New +$944K

Similar funds

Squarepoint's Q2 2025 Portfolio in Review

As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
  • Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
  • Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
  • Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
  • Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
  • Squarepoint opened 767 new positions and closed 817 in Q2 2025.
  • Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.